Global Gabapentin Market by Manufacturers, Regions, Type and Application, Forecast to 2021

According to Custom Market Inights analysis, The global gabapentin market is expected to register a healthy CAGR during the period from 2016 to 2025. This report studies the gabapentin status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the gabapentin by product type and applications/end industries.

Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain.

Scope of the Report:

This report focuses on the Gabapentin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Pfizer, GSK, Sailike, Jiangsu Enhua, Jiangsu Hengrui, Novartis, Actavis, Glenmark

Market Segment by Regions, regional analysis covers

North America (USA, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America, Middle East and Africa

Market Segment by Type, covers

Tablet

Capsule

Market Segment by Applications, can be divided into

Nerve Pain

Restless Legs Syndrome

Seizures

There are 13 Chapters to deeply display the global Gabapentin market.

Chapter 1, to describe Gabapentin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Gabapentin, with sales, revenue, and price of Gabapentin, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Gabapentin, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;

Chapter 11, Gabapentin market forecast, by regions, type and application, with sales and revenue, from 2016 to 2021;

Chapter 12 and 13, to describe Gabapentin sales channel, distributors, traders, dealers, appendix and data source.

Table of Contents

Global Gabapentin Market by Manufacturers, Regions, Type and Application, Forecast to 2021

1 Market Overview

1.1 Gabapentin Introduction

1.2 Market Analysis by Type

1.2.1 Tablet

1.2.2 Capsule

1.3 Market Analysis by Applications

1.3.1 Nerve Pain

1.3.2 Restless Legs Syndrome

1.3.3 Seizures

1.4 Market Analysis by Regions

1.4.1 North America (USA, Canada and Mexico)

1.4.1.1 USA

1.4.1.2 Canada

1.4.1.3 Mexico

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany

1.4.2.2 France

1.4.2.3 UK

1.4.2.4 Russia

1.4.2.5 Italy

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China

1.4.3.2 Japan

1.4.3.3 Korea

1.4.3.4 India

1.4.3.5 Southeast Asia

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil

1.4.4.2 Egypt

1.4.4.3 Saudi Arabia

1.4.4.4 South Africa

1.4.4.5 Nigeria

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer

2.1.1 Business Overview

2.1.2 Gabapentin Type and Applications

2.1.2.1 Type 1

2.1.2.2 Type 2

2.1.3 Pfizer Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.2 GSK

2.2.1 Business Overview

2.2.2 Gabapentin Type and Applications

2.2.2.1 Type 1

2.2.2.2 Type 2

2.2.3 GSK Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.3 Sailike

2.3.1 Business Overview

2.3.2 Gabapentin Type and Applications

2.3.2.1 Type 1

2.3.2.2 Type 2

2.3.3 Sailike Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.4 Jiangsu Enhua

2.4.1 Business Overview

2.4.2 Gabapentin Type and Applications

2.4.2.1 Type 1

2.4.2.2 Type 2

2.4.3 Jiangsu Enhua Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.5 Jiangsu Hengrui

2.5.1 Business Overview

2.5.2 Gabapentin Type and Applications

2.5.2.1 Type 1

2.5.2.2 Type 2

2.5.3 Jiangsu Hengrui Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.6 Novartis

2.6.1 Business Overview

2.6.2 Gabapentin Type and Applications

2.6.2.1 Type 1

2.6.2.2 Type 2

2.6.3 Novartis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.7 Actavis

2.7.1 Business Overview

2.7.2 Gabapentin Type and Applications

2.7.2.1 Type 1

2.7.2.2 Type 2

2.7.3 Actavis Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

2.8 Glenmark

2.8.1 Business Overview

2.8.2 Gabapentin Type and Applications

2.8.2.1 Type 1

2.8.2.2 Type 2

2.8.3 Glenmark Gabapentin Sales, Price, Revenue, Gross Margin and Market Share

3 Global Gabapentin Market Competition, by Manufacturer

3.1 Global Gabapentin Sales and Market Share by Manufacturer

3.2 Global Gabapentin Revenue and Market Share by Manufacturer

3.3 Market Concentration Rate

3.3.1 Top 3 Gabapentin Manufacturer Market Share

3.3.2 Top 6 Gabapentin Manufacturer Market Share

3.4 Market Competition Trend

4 Global Gabapentin Market Analysis by Regions

4.1 Global Gabapentin Sales, Revenue and Market Share by Regions

4.1.1 Global Gabapentin Sales by Regions (2011-2016)

4.1.2 Global Gabapentin Revenue by Regions (2011-2016)

4.2 North America Gabapentin Sales and Growth (2011-2016)

4.3 Europe Gabapentin Sales and Growth (2011-2016)

4.4 Asia-Pacific Gabapentin Sales and Growth (2011-2016)

4.5 South America Gabapentin Sales and Growth (2011-2016)

4.6 Middle East and Africa Gabapentin Sales and Growth (2011-2016)

5 North America Gabapentin by Countries

5.1 North America Gabapentin Sales, Revenue and Market Share by Countries

5.1.1 North America Gabapentin Sales by Countries (2011-2016)

5.1.2 North America Gabapentin Revenue by Countries (2011-2016)

5.2 USA Gabapentin Sales and Growth (2011-2016)

5.3 Canada Gabapentin Sales and Growth (2011-2016)

5.4 Mexico Gabapentin Sales and Growth (2011-2016)

6 Europe Gabapentin by Countries

6.1 Europe Gabapentin Sales, Revenue and Market Share by Countries

6.1.1 Europe Gabapentin Sales by Countries (2011-2016)

6.1.2 Europe Gabapentin Revenue by Countries (2011-2016)

6.2 Germany Gabapentin Sales and Growth (2011-2016)

6.3 UK Gabapentin Sales and Growth (2011-2016)

6.4 France Gabapentin Sales and Growth (2011-2016)

6.5 Russia Gabapentin Sales and Growth (2011-2016)

6.6 Italy Gabapentin Sales and Growth (2011-2016)

7 Asia-Pacific Gabapentin by Countries

7.1 Asia-Pacific Gabapentin Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Gabapentin Sales by Countries (2011-2016)

7.1.2 Asia-Pacific Gabapentin Revenue by Countries (2011-2016)

7.2 China Gabapentin Sales and Growth (2011-2016)

7.3 Japan Gabapentin Sales and Growth (2011-2016)

7.4 Korea Gabapentin Sales and Growth (2011-2016)

7.5 India Gabapentin Sales and Growth (2011-2016)

7.6 Southeast Asia Gabapentin Sales and Growth (2011-2016)

8 South America, Middle East and Africa Gabapentin by Countries

8.1 South America, Middle East and Africa Gabapentin Sales, Revenue and Market Share by Countries

8.1.1 South America, Middle East and Africa Gabapentin Sales by Countries (2011-2016)

8.1.2 South America, Middle East and Africa Gabapentin Revenue by Countries (2011-2016)

8.2 Brazil Gabapentin Sales and Growth (2011-2016)

8.3 Saudi Arabia Gabapentin Sales and Growth (2011-2016)

8.4 Egypt Gabapentin Sales and Growth (2011-2016)

8.5 Nigeria Gabapentin Sales and Growth (2011-2016)

8.6 South Africa Gabapentin Sales and Growth (2011-2016)

9 Gabapentin Market Segment by Type

9.1 Global Gabapentin Sales, Revenue and Market Share by Type (2011-2016)

9.1.1 Global Gabapentin Sales and Market Share by Type (2011-2016)

9.1.2 Global Gabapentin Revenue and Market Share by Type (2011-2016)

9.2 Tablet Sales Growth and Price

9.2.1 Global Tablet Sales Growth (2011-2016)

9.2.2 Global Tablet Price (2011-2016)

9.3 Capsule Sales Growth and Price

9.3.1 Global Capsule Sales Growth (2011-2016)

9.3.2 Global Capsule Price (2011-2016)

10 Gabapentin Market Segment by Application

10.1 Global Gabapentin Sales Market Share by Application (2011-2016)

10.2 Nerve Pain Sales Growth (2011-2016)

10.3 Restless Legs Syndrome Sales Growth (2011-2016)

10.4 Seizures Sales Growth (2011-2016)

11 Gabapentin Market Forecast (2016-2021)

11.1 Global Gabapentin Sales, Revenue and Growth Rate (2016-2021)

11.2 Gabapentin Market Forecast by Regions (2016-2021)

11.3 Gabapentin Market Forecast by Type (2016-2021)

11.4 Gabapentin Market Forecast by Application (2016-2021)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Future Trend

12.2 Distributors, Traders and Dealers

13 Appendix

13.1 Methodology

13.2 Analyst Introduction

13.3 Data Source

Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Name: (required)

Email: (required)

Phone: (required)

Company: (required)

Designation: (required)

Country: (required)

How can we help you?:

Type the pieces of text below (required)
captcha



Jacob Thomass